Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Platt

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2013
Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasiaAndrew M Platt, Joseph M Rutkowski, Catherine Martel, et al.
Rheumatology (Oxford, England)|July 28, 2014
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cellsAndrew M Platt, Robert A Benson, Ross McQueenie, et al.
Immunology Letters|March 23, 2011
Putative existence of reciprocal dialogue between Tfh and B cells and its impact on infectious and autoimmune diseaseAgapitos Patakas, Andrew M Platt, John P Butcher, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cellsAndrew M Platt, Vivienne B Gibson, Agapitos Patakas, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 18, 2023
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®Jonathan I Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 yearsChristopher G Bunick, Alan D Irvine, Jonathan I Silverberg, et al.
The Journal of Clinical Investigation|March 26, 2013
Lymphatic vasculature mediates macrophage reverse cholesterol transport in miceCatherine Martel, Wenjun Li, Brian Fulp, et al.
Dermatology and Therapy|August 7, 2024
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic DermatitisAndrew Blauvelt, Kilian Eyerich, Alan D Irvine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2015
Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node-homing adipose tissue dendritic cellsEmma L Kuan, Stoyan Ivanov, Eric A Bridenbaugh, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2013
Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasiaAndrew M Platt, Joseph M Rutkowski, Catherine Martel, et al.
Rheumatology (Oxford, England)|July 28, 2014
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cellsAndrew M Platt, Robert A Benson, Ross McQueenie, et al.
Immunology Letters|March 23, 2011
Putative existence of reciprocal dialogue between Tfh and B cells and its impact on infectious and autoimmune diseaseAgapitos Patakas, Andrew M Platt, John P Butcher, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cellsAndrew M Platt, Vivienne B Gibson, Agapitos Patakas, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 18, 2023
Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®Jonathan I Silverberg, Marjolein de Bruin-Weller, Brian M Calimlim, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 yearsChristopher G Bunick, Alan D Irvine, Jonathan I Silverberg, et al.
The Journal of Clinical Investigation|March 26, 2013
Lymphatic vasculature mediates macrophage reverse cholesterol transport in miceCatherine Martel, Wenjun Li, Brian Fulp, et al.
Dermatology and Therapy|August 7, 2024
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic DermatitisAndrew Blauvelt, Kilian Eyerich, Alan D Irvine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2015
Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node-homing adipose tissue dendritic cellsEmma L Kuan, Stoyan Ivanov, Eric A Bridenbaugh, et al.
Pageof 3